Screening for Cancers in the Oral CAvity
ConditionOral Cavity Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-75
SponsorCentre Hospitalier Universitaire, Amiens
About this trial
In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media).
The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme
lives in somme departement
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Invitation for oral cavity cancer screening
Other intervention
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Screening for cancers in the oral cavityOther 1 intervention
Trial outcomes
Primary outcomes
1
Participation rate to the screening of the target patients.
Numbers of people who benefit from a screening exam by a physician of the Somme region in comparison, with the target population of the Somme region. This rate will be also calculated according the different of age and sex.
Time frame
03 months after the start of the incentive periodSecondary outcomes
1
The participation rate of the physicians.
Number of physicians who send back at least one clinical form compared to the numbers of physician of the Somme.
Time frame
03 months after the start of the incentive period2
The participation rate of the tobacco venders.
The number of tobacco venders who gave at least 01 " Flyer " in comparison to the numbers of tobacco venders of the Somme.
Time frame
15 days after the start of the incentive periodSponsors and contacts
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Picardy - Regional health agency (ARS)
Collaborator
Regional Council Picardie
Collaborator
Regional Observatory of Health and Social Issues in Picardie (OR2S)
Collaborator
Association for the screening of diseases in Somme (Adema 80)
Collaborator
Somme Cancer Registry
Collaborator
Source ClinicalTrials.gov